Publications by authors named "James Gasper"

Claim this Profile
D
Dose trajectories associated with non-fatal overdose among patients co-prescribed opioids and benzodiazepines: Retrospective cohort study.
Joshua J Fenton, Shao-You Fang, Susan Stewart, Iraklis Erik Tseregounis, Alicia Agnoli, James J Gasper

Drug Alcohol Depend· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Incident Benzodiazepine Co-prescription Among Patients Prescribed Long-term Opioids.
Iraklis Erik Tseregounis, Stephen G Henry, Shao-You Fang, Susan Stewart, Alicia Agnoli, James J Gasper

J Gen Intern Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up and reasons for extended-release naltrexone discontinuation for alcohol use disorder after hospital initiation.
Marlene Martin, Manuel Seraydarian, James Gasper, Triveni DeFries

BMJ Open Qual· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study.
Stephen G Henry, Shao-You Fang, Andrew J Crawford, Garen J Wintemute, Iraklis Erik Tseregounis, James J Gasper

J Gen Intern Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-Based Guidelines for Prehospital Pain Management: Recommendations.
George Lindbeck, Manish I Shah, Sabina Braithwaite, Jonathan R Powell, Ashish R Panchal, James Gasper

Prehosp Emerg Care· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release naltrexone for people with alcohol use disorder on therapeutic anticoagulation: A case series.
Katrina Ciraldo, Manuel Seraydarian, James Gasper, Triveni DeFries, Marlene Martin

J Clin Pharm Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of California wildfires on patient access to prescription opioids.
Iraklis E Tseregounis, Chris Delcher, Susan L Stewart, James J Gasper, Aaron B Shev

J Am Pharm Assoc (2003)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study.
Stephen G Henry, Susan L Stewart, Eryn Murphy, Iraklis Erik Tseregounis, Andrew J Crawford, James J Gasper

J Gen Intern Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Risk Prediction Model for Long-term Prescription Opioid Use.
Iraklis E Tseregounis, Daniel J Tancredi, Susan L Stewart, Aaron B Shev, Andrew Crawford, James J Gasper

Med Care· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Buprenorphine to Treat Opioid Use Disorder in California, 2012 to 2018: Medicaid Outpaces the Rest of the State.
Iraklis Erik Tseregounis, James J Gasper, Stephen G Henry

J Addict Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist furnishing of naloxone in California: A follow-up analysis.
Talia Puzantian, James J Gasper, Christina M Ramirez

J Am Pharm Assoc (2003)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-Based Guidelines for EMS Administration of Naloxone.
Kenneth Williams, Eddy S Lang, Ashish R Panchal, James J Gasper, Peter Taillac

Prehosp Emerg Care· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provision of Naloxone Without a Prescription by California Pharmacists 2 Years After Legislation Implementation.
Talia Puzantian, James J Gasper

JAMA· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients.
Sharon M Hall, Gary L Humfleet, James J Gasper, Kevin L Delucchi, David F Hersh

Nicotine Tob Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
Phillip Oliver Coffin, Glenn-Milo Santos, Moupali Das, Deirdre M Santos, Shannon Huffaker, James Gasper

Addiction· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirtazapine to reduce methamphetamine use: a randomized controlled trial.
Grant N Colfax, Glenn-Milo Santos, Moupali Das, Deirdre McDermott Santos, Tim Matheson, James Gasper

Arch Gen Psychiatry· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinsonism with intramuscular ziprasidone.
Louai Bilal, Carloine Tsai, James J Gasper, J Charles Ndlela

Am J Psychiatry· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis